FDA Warning Letter — Sinsin Pharmaceutical Co., Ltd.

Case 718720 — FEI 3002277609

The FDA took a Warning Letter action against Sinsin Pharmaceutical Co., Ltd. on November 12, 2025 (Sejong, South Korea). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Sinsin Pharmaceutical Co., Ltd.
Date
November 12, 2025
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Sejong (South Korea)